Fingerprint
Dive into the research topics of 'Phase i dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase i dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors
Andrew J. Brenner, Yael C. Cohen, Eyal Breitbart, Livnat Bangio, John Sarantopoulos, Francis J. Giles, Ernest C. Borden, Dror Harats, Pierre L. Triozzi*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations